IL6 and Alzheimer disease: In vitro, we found that exposure of astrocytes to Aβ1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].